Literature DB >> 32014680

Structural features and functional activities of benzimidazoles as NOD2 antagonists.

Samo Guzelj1, Martina Gobec1, Dunja Urbančič1, Irena Mlinarič-Raščan1, Emanuela Corsini2, Žiga Jakopin3.   

Abstract

NOD1 and NOD2 are pattern recognition receptors that have important roles in innate immune responses. Although their overactivation has been linked to a number of diseases, NOD2 in particular remains a virtually unexploited target in this respect, with only one structural class of antagonist reported. To gain insight into the structure-activity relationships of NOD2 antagonists, a series of novel analogs was designed and synthesized, and then screened for antagonist activity versus NOD2, and counter-screened versus NOD1. Compounds 32 and 38 were identified as potent and moderately selective NOD2 antagonists, and 33 and 42 as dual NOD1/NOD2 antagonists, with balanced activities against both targets in the low micromolar range. These data enable in-depth exploration of their structure-activity relationships and provide deeper understanding of the structural features required for NOD2 antagonism.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Immunomodulation; Interleukin-8; NF-κB activation; NOD1 antagonist; NOD2 antagonist; Tumor necrosis factor-α

Year:  2020        PMID: 32014680     DOI: 10.1016/j.ejmech.2020.112089

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency.

Authors:  Samo Guzelj; Špela Bizjak; Žiga Jakopin
Journal:  ACS Med Chem Lett       Date:  2022-07-18       Impact factor: 4.632

2.  Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening.

Authors:  Samo Guzelj; Tihomir Tomašič; Žiga Jakopin
Journal:  Biomolecules       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.